BTIG Downgrades Voyager Therapeutics (VYGR) to Neutral
- Wall Street ends week positively; S&P 500, Dow hit record highs
- Bitcoin (BTC) Drops 3% as Turkey Bans Cryptocurrency Payments Citing Lack of Regulatory Supervision
- Morgan Stanley (MS) Archegos-Related Loss Appears to be $911M
- Dollar at 4-week low on retreating Treasury yields
BTIG analyst Thomas Shrader downgraded Voyager Therapeutics (NASDAQ: VYGR) from Buy to Neutral.
Shares of Voyager Therapeutics closed at $7.11 yesterday.
You May Also Be Interested In
- UPDATE: Morgan Stanley Downgrades Goodyear Tire & Rubber (GT) to Equalweight
- Deutsche Bank Downgrades PPD Inc. (PPD) to Hold
- Canaccord Genuity Downgrades Kainos Group Plc. (KNOS:LN) to Hold